Interim safety analysis of cancer immunotherapy trials Network – 12 (CITN-12): a Phase 1 study of pembrolizumab in patients with HIV and cancer

• T.S. Uldrick,
• M.A. ‘Mac’ Cheever,
• P.H. Gonçalves,
• S. Fling,
• K. Aleman,
• B. Emu,
• M.S. Ernstoff,
• R. Gorelick,
• J. Kaiser,
• H. E Kohrt,
• A. Lacroix,
• M. Lindsley,
• L. M Lundgren,
• K. Lurain,
• F. Maldarelli,
• C. Parsons,
• E. Sharon,
• A. Widell,
• R. Yarchoan

Affiliations

T.S. Uldrick

National Cancer Institute, HIV and AIDS Malignancy Branch, Bethesda, MD, USA

M.A. ‘Mac’ Cheever

Cancer Immunotherapy Trials Network/Fred Hutchinson Cancer Res Center, Seattle, WA, USA

P.H. Gonçalves

National Cancer Institute, HIV and AIDS Malignancy Branch, Bethesda, MD, USA

S. Fling

Cancer Immunotherapy Trials Network/Fred Hutchinson Cancer Res Center, Seattle, WA, USA

K. Aleman

National Cancer Institute, HIV and AIDS Malignancy Branch, Bethesda, MD, USA

B. Emu

Yale University, Medicine/Oncology, New Haven, CN, USA

M.S. Ernstoff

Roswell Park Cancer Institute, Buffalo, NY, USA

R. Gorelick

National Cancer Institute at Frederick, AIDS and Cancer Virus Program, Frederick, MD, USA

J. Kaiser

Cancer Immunotherapy Trials Network/Fred Hutchinson Cancer Res Center, Seattle, WA, USA

H. E Kohrt

Stanford University, Medicine/Oncology, Stanford, CA, USA

A. Lacroix

Cancer Immunotherapy Trials Network/Fred Hutchinson Cancer Res Center, Seattle, WA, USA

M. Lindsley

National Cancer Institute, HIV and AIDS Malignancy Branch, Bethesda, MD, USA

L. M Lundgren

Cancer Immunotherapy Trials Network/Fred Hutchinson Cancer Res Center, Seattle, WA, USA

K. Lurain

National Cancer Institute, HIV and AIDS Malignancy Branch, Bethesda, MD, USA

F. Maldarelli

National Cancer Institute, HIV Dynamics and Replication Program, Frederick, MD, USA

C. Parsons

Louisiana State University Health Science Center, New Orleans, LA, USA

E. Sharon

National Cancer Institute, Cancer Therapy and Evaluation Program, Bethesda, MD, USA

A. Widell

National Cancer Institute, HIV and AIDS Malignancy Branch, Bethesda, MD, USA

R. Yarchoan

National Cancer Institute, HIV and AIDS Malignancy Branch, Bethesda, MD, USA